logo
UK Cancer Deaths Drop 22% in 50 Years Despite Rising Cases

UK Cancer Deaths Drop 22% in 50 Years Despite Rising Cases

Medscape2 days ago

Cancer death rates in the UK have fallen by 22% over the past 50 years. However, diagnoses have risen by almost half, according to a new analysis by Cancer Research UK (CRUK).
The Cancer in the UK Report 2025 provides the first 50 years of UK-wide data on cancer mortality and cases. Death rates fell from around 328 per 100,000 people in 1973 to around 252 per 100,000 in 2023.
CRUK described the findings as 'profound'. The charity said improvements in diagnosis, treatment, and smoking reduction had helped drive the decline.
People today are twice as likely to survive their disease for at least 10 years compared to 50 years ago. Survival rates improved from one in four people in the early 1970s to one in two today.
Rising Incidence Despite Progress
Cancer incidence rates increased sharply by 47% during the same period. Cases rose from around 413 to 607 per 100,000 people.
However, the charity noted that because of the UK's growing and ageing population, actual numbers continue to rise. Nearly 1100 new cases are diagnosed daily, with more than 460 deaths each day.
This occurs despite significant progress in prevention, detection, diagnosis, and treatment.
CRUK called on the government to ensure that its upcoming National Cancer Plan for England is 'ambitious and fully funded'.
Early Diagnosis Rates Stagnant
Research into improving screening programmes, tests, and drugs helped reduce death rates. Policy action on smoking reduced rates for cancers with poor survival outcomes.
Lung cancer mortality rates decreased from 80.9 per 100,000 people in 1971-1973 to 49.8 in 2021-2023. Bowel cancer rates fell from 48.0 to 26.3, whilst breast cancer dropped from 30.7 to 16.9.
However, pancreatic cancer rates remained stable at around 15 per 100,000 people. Some cancers showed increases, including prostate cancer from 13.3 to 18.3 and oesophageal cancer from 9.2 to 12.0.
Just over half of cancers (54%) were diagnosed at an early stage in England, the report found. This proportion has not changed for almost a decade.
Around half of all new cancer diagnoses occur in people aged 70 and over. However, incidence rates are rising fastest in younger people, with a 23% increase in people aged 20 to 49 since the early 1990s.
Screening Programmes Save Lives
Three cancer screening programmes save around 5000 lives every year across the UK, according to CRUK.
Smoking remains the biggest cause of cancer in the UK. It accounts for around a fifth of all cancer deaths each year. Around one in 20 UK cancer deaths are now linked to being overweight or obese.
​Michelle Mitchell, CRUK's chief executive, welcomed the reduced death rates and doubled survival rates. However, she stressed that too many cases are diagnosed at a late stage.
"If we want to change that, we need bold action from the UK government," Mitchell said.
Professor Peter Johnson, NHS national clinical director for cancer, highlighted recent innovations. These include lung cancer screening in car parks and AI technology to spot skin cancer.
Mitchell urged that the upcoming National Cancer Plan for England must improve survival and transform services. She said the plan "could save countless lives across England and ensure people affected by cancer live longer, better lives".
CRUK has also published devolved nation summaries of its findings for Scotland, Wales, and Northern Ireland.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dogs in danger as grass seed season approaches
Dogs in danger as grass seed season approaches

Yahoo

time24 minutes ago

  • Yahoo

Dogs in danger as grass seed season approaches

As grass seed season approaches, vets are warning dog owners to be aware of the pointy seeds. Over the next three months, pooches are at risk of getting the dangerous seeds wedged in their fur. The seeds are commonly found in ears, paws, armpits, chest and sometimes eyes. Dogs with longer or curlier coats should be trimmed (Image: Denise Bradley) Last year, a dog in Norwich was rushed into surgery after inhaling a grass seed that punctured her lung. Dr Rosemary Smith, who runs a mobile veterinary service named Paws Indoors across Norwich and South Norfolk, has advised dog owners of what to be aware of. "The ends are very sharp and can pierce the skin," she said. "The long strong hairs that are rough and ratcheted force the seed forward." Symptoms include head shaking, licking at a paw, swollen paws or lameness. READ MORE: "The shaking is usually troublesome to the dog as the seed is quickly shaken to the bottom of the ear, out of sight, where it irritates the delicate eardrum," she added. To help prevent the seeds from causing serious issues, dogs with longer or curlier coats should be trimmed and owners need to inspect their furry friend after each walk. Although seeds can be removed at home if they are loose and easily picked out, Dr Smith advises seeking veterinary attention if "your dog suddenly and persistently shakes its head, or is persistently licking its paws". In the more severe cases, where a seed may have broken off, exploratory surgery may be required.

Fevertree and Molson Coors to split cost of US tariffs
Fevertree and Molson Coors to split cost of US tariffs

Yahoo

time27 minutes ago

  • Yahoo

Fevertree and Molson Coors to split cost of US tariffs

(Reuters) -Tonic maker Fevertree Drinks said on Thursday it would equally split costs of the 10% tariff to be imposed on the UK imports to the U.S. with brewer Molson Coors, as part of their recent tie-up to mitigate the short-term impact. Fevertree also said that Charles Gibb, its North America CEO, will step down and be succeeded by Judd Hausner, who brings extensive experience from the U.S. beer network. The British company, known for its premium cocktail mixers, counts the United States as its largest market, where it continues to deliver strong momentum bolstered by its partnership with the U.S. beer maker Molson Coors. In January, Molson Coors took a stake in Fevertree, securing exclusive rights to distribute and market the British company's cocktail mixers and tonic waters in the U.S. Fevertree reiterated its annual revenue growth forecast. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store